Psilocybin 5 mg with cognitive behavioural therapy intervention clinical trials

PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm

This study looks at how a small dose of psilocybin, combined with mental imagery therapy, might help young people aged 16-25 who self-harm. It aims to make therapy more effective and easier to engage with.